Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine | Nature Communications
Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides | PNAS
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer - eBioMedicine
Frontiers | KRAS protein expression becomes progressively restricted during embryogenesis and in adulthood
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer | Nature Reviews Gastroenterology & Hepatology
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Mutant KRAS is continuously in a GTP‐bound, active state. Wild‐type... | Download Scientific Diagram
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine
KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge | Cell Discovery
KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences
KRAS oncogene in lung cancer: focus on molecularly driven clinical trials | European Respiratory Society
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein | PNAS
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research
Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors | Anticancer Research
Acquired Resistance to KRASG12C Inhibition in Cancer | NEJM
An overview of upstream and downstream effectors of KRAS. (Figure... | Download Scientific Diagram
